Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint and openWorldHint, but the description adds genuinely new behavior: a hard 10-per-call cap, per-call cost of $0.002 USDC via x402 across three chains, and that failed calls are not billed. That billing/failure policy is exactly the kind of thing annotations cannot express.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

Two dense sentences, front-loaded with the identity of the resource, then field list, then limits and pricing. No filler, and every clause carries information an agent needs.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With an output schema present, the description needn't explain return structure, and annotations cover the read-only profile. It also states the cap and cost, covering the main operational risks. A minor gap is not mentioning rate limits or pagination beyond the 10-item cap.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so both parameters are already documented in the schema with ranges and defaults. The description only restates the max=10 ceiling; it adds no syntax guidance for the free-text search term. Baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

Names a specific verb and resource ('ClinicalTrials.gov study search (API v2)') and enumerates the returned study fields, so an agent knows exactly what it retrieves. It does not explicitly contrast itself with neighbors like health_pubmed_abstracts or health_clinical_evidence_cochrane, which is the only thing keeping it off a 5.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

Usage is implied by the search-term hint (condition, drug, sponsor) and the 10-study cap, but there is no explicit when-to-use / when-not-to-use statement or named alternative. The agent must infer that this is the registry lookup rather than a literature or systematic-review source.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.